Literature DB >> 1538834

Evidence for increased lipid peroxidation in multiple sclerosis.

P K Toshniwal1, E J Zarling.   

Abstract

Pentane and ethane are degradation products of unsaturated fatty acids which are released during lipid peroxidation. In order to assess whether multiple sclerosis is associated with lipid peroxidation, we measured pentane and ethane excretion by 16 patients with multiple sclerosis and compared them to healthy control subjects. Patients with acute exacerbation of multiple sclerosis had significantly higher concentrations of pentane (10.5 +/- 4.2 nmol/l)(p less than 0.01) compared to either patients in remission (4.5 +/- 1.7 nmol/l) or control subjects (4.9 +/- 1.1 nmol/l). The concentrations of ethane were not significantly different among these groups. Of the patients with acute exacerbation who later achieved remission, the pentane excretion also returned to normal (5.6 +/- 0.9 nmol/l). One patient who failed to reachieve clinical remission continued to excrete large amounts of pentane. We conclude that oxygen free radical activity is enhanced during exacerbation of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538834     DOI: 10.1007/bf00966801

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

Review 1.  Multiple sclerosis: a new hypothesis.

Authors:  H S Mickel
Journal:  Perspect Biol Med       Date:  1975       Impact factor: 1.416

2.  Peroxidase activity in glia and ependymocytes of the mouse brain.

Authors:  Z Srebro; T Cichocki; J Godula
Journal:  Acta Morphol Acad Sci Hung       Date:  1971

Review 3.  Vitamin E deficiency and neurologic disease.

Authors:  R J Sokol
Journal:  Annu Rev Nutr       Date:  1988       Impact factor: 11.848

4.  Overview of methods used for detecting lipid peroxidation.

Authors:  T F Slater
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Effect of reactive oxygen species on myelin membrane proteins.

Authors:  G W Konat; R C Wiggins
Journal:  J Neurochem       Date:  1985-10       Impact factor: 5.372

6.  Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation.

Authors:  C J Dillard; R E Litov; W M Savin; E E Dumelin; A L Tappel
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-12

7.  Volatile hydrocarbon and carbonyl products of lipid peroxidation: a comparison of pentane, ethane, hexanal, and acetone as in vivo indices.

Authors:  C J Dillard; A L Tappel
Journal:  Lipids       Date:  1979-12       Impact factor: 1.880

8.  Release of ethane and pentane from rat tissue slices: effect of vitamin E, halogenated hydrocarbons, and iron overload.

Authors:  V C Gavino; C J Dillard; A L Tappel
Journal:  Arch Biochem Biophys       Date:  1984-09       Impact factor: 4.013

9.  Assessment of lipid peroxidation in newborn infants and rabbits by measurements of expired ethane and pentane: influence of parenteral lipid infusion.

Authors:  J R Wispe; E F Bell; R J Roberts
Journal:  Pediatr Res       Date:  1985-04       Impact factor: 3.756

10.  Breath pentane excretion as a marker of disease activity in rheumatoid arthritis.

Authors:  S Humad; E Zarling; M Clapper; J L Skosey
Journal:  Free Radic Res Commun       Date:  1988
View more
  28 in total

Review 1.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

Review 3.  Antioxidants in multiple sclerosis: do they have a role in therapy?

Authors:  Noel G Carlson; John W Rose
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  T-cell recognition of lipid peroxidation products breaks tolerance to self proteins.

Authors:  D M Wuttge; M Bruzelius; S Stemme
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

5.  Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms.

Authors:  Hyung-Lok Chung; Michael F Wangler; Paul C Marcogliese; Juyeon Jo; Thomas A Ravenscroft; Zhongyuan Zuo; Lita Duraine; Sina Sadeghzadeh; David Li-Kroeger; Robert E Schmidt; Alan Pestronk; Jill A Rosenfeld; Lindsay Burrage; Mitchell J Herndon; Shan Chen; Amelle Shillington; Marissa Vawter-Lee; Robert Hopkin; Jackeline Rodriguez-Smith; Michael Henrickson; Brendan Lee; Ann B Moser; Richard O Jones; Paul Watkins; Taekyeong Yoo; Soe Mar; Murim Choi; Robert C Bucelli; Shinya Yamamoto; Hyun Kyoung Lee; Carlos E Prada; Jong-Hee Chae; Tiphanie P Vogel; Hugo J Bellen
Journal:  Neuron       Date:  2020-03-12       Impact factor: 17.173

6.  Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.

Authors:  Marcus Koch; Geeta S M Ramsaransing; Alexander V Arutjunyan; Michael Stepanov; Albert Teelken; Dorothea J Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

Review 7.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 8.  Gemfibrozil, stretching arms beyond lipid lowering.

Authors:  Avik Roy; Kalipada Pahan
Journal:  Immunopharmacol Immunotoxicol       Date:  2009       Impact factor: 2.730

9.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

10.  IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Authors:  Rebecca A Sosa; Cathi Murphey; Rachel R Robinson; Thomas G Forsthuber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.